首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Preparation of new polycyclic compounds derived from benzofurans and furochromones. An approach to novel 1,2,3-thia-, and selena-diazolofurochromones of anticipated antitumor activities.
【24h】

Preparation of new polycyclic compounds derived from benzofurans and furochromones. An approach to novel 1,2,3-thia-, and selena-diazolofurochromones of anticipated antitumor activities.

机译:衍生自苯并呋喃和呋染酮的新多环化合物的制备。 一种新的1,2,3-尖头和塞雷娜二唑的方法的方法预期的抗肿瘤活动。

获取原文
获取原文并翻译 | 示例
       

摘要

Base catalyzed condensation of enaminoketones (3a,b) with malononitrile yields the respective 7-imino-5[2(substituted)prop-1-enyl]furochromene-6-carbonitriles (4a-d) according to the nature of base used. Compounds (3a, b) condense also with indan-1,3-diketone (5) to give alpha, beta-unsaturated carbonyl compounds (6a) and (6b), respectively. Pyrrolidine-catalyzed condensation of visnaginone (2a) and khellinone (2b) with active methylenes yields the corresponding 1-[7,7-(substituted) furobenzodihydropyrone derivatives (7a-e) which condense with semicarbazide to give the respective semicarbazones (8a-e). Compounds (8b,e) react with thionyl chloride to give the respective 1,2,3-thiadiazoles (9a,b) meanwhile compounds (8a-e) react also with selenium dioxide to give 1,2,3-selenadiazoles (9c-g), respectively. Chalcones (11a,b) were obtained upon condensing (2a,b) with ferrocene-2-carboxaldehyde (10). Compatible elementary and spectroscopic measurements were in good accord with the structures postulated for the new compounds. The antitumor activities of certain selected new compounds were screened, in vitro, against a panel of four (breast: MCF-7, cervix: HELA, colon: HCT116 and liver: HEPG2) human solid tumor cell lines and the structure activity relationship (SAR) was discussed.
机译:用丙二腈的酶氧代酮(3A,B)的碱催化缩合产生各自的7-亚氨基-5 [2(取代的)丙-1-烯基]偶氯丙烯-6-腈(4A-D),根据所用基础的性质。化合物(3A,B)冷凝,也具有茚满-1,3-二酮(5),分别得到α,β-不饱和羰基化合物(6A)和(6B)。 visnaginone(2a)和khellinone(2b)中与活性亚甲基的吡咯烷催化缩合,得到相应的1- [7,7-(取代的)furobenzodihydropyrone衍生物(图7a-e)在与冷凝氨基脲,得到相应的缩氨基脲(8A-E )。化合物(8b,e)与亚氯酰氯反应,得到相应的1,2,3-噻二唑(9a,b)同时化合物(8a-e)也与二氧化硒反应,得到1,2,3-硒唑(9c- g)分别。在用二茂铁-2-羧醛(10)冷凝(2a,b)时得到Chalcones(11a,b)。兼容的基本和光谱测量符合新化合物假定的结构。某些选定的新化合物的抗肿瘤活性在体外,对抗四个面板(乳房:MCF-7,Cerfix:Hela,结肠:Hct116和肝脏:Hepg2)人类实体肿瘤细胞系和结构活动关系(SAR )被讨论过。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号